IPO Trending
HAMPSSME / BSEListed

Hamps Bio Limited

Hamps Bio Limited, incorporated in 2007, is engaged in marketing and distributing pharmaceutical products under the “Hamps” brand and freeze-dried and frozen FMCG items under the “FzyEzy” brand. Its pharmaceutical portfolio includes tablets, syrups, capsules, injectables, and powders, distributed across eight Indian states and union territories through 50+ distributors and online platforms such as Amazon, Flipkart, and Jio Mart. The company’s FMCG division offers freeze-dried and frozen products like strawberry, mango, and beet powders for both B2B and B2C markets, including contract manufacturing. With a portfolio of 180+ products across both verticals, Hamps Bio serves domestic and international markets and employed 78 people as of October 31, 2024.

₹51 - ₹511050.21x sub
Listed Price96.90
Listing Gain+90.00%
FinancialsBalance sheet and operational figures in Crores
Metric Breakdown

Revenue

Latest (Oct-24 )436 Cr
Growth-18.4%
Revenue Trend (₹ in Crores)
0.0249.2498.3747.5Mar-22Mar-23 Mar-24 Oct-24
PeriodRev (Cr)PAT (Cr)AssetsDebt
Oct-24 43634644138
Mar-24 65050515105
Mar-23 55836 396174
Mar-2253412364204
Key Performance Indicators (KPIs)
PeriodEPSROEROCEP/E (Pre)P/E (Post)
Oct-241.0916.65%18.53%00
Mar-241.7621.14%18.31%31.9438.03
Mar-231.530.31%17.43%00